These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19726317)

  • 1. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
    Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
    Wang XL; Li H; Wang QS; Zhang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
    Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
    J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
    Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
    J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
    Zheng JH; Chang ZH; Han CB; Ma JT; Liu ZY; Lu ZM; Guo QY
    Nucl Med Commun; 2014 Apr; 35(4):339-46. PubMed ID: 24323312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
    Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
    Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
    Travaini LL; Trifirò G; Ravasi L; Monfardini L; Della Vigna P; Bonomo G; Chiappa A; Mallia A; Ferrari M; Orsi F; Paganelli G
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1316-22. PubMed ID: 18338164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
    Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
    J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
    Chen W; Zhuang H; Cheng G; Torigian DA; Alavi A
    Ann Nucl Med; 2013 Jan; 27(1):58-64. PubMed ID: 23054830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
    Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition.
    Shyn PB; Tatli S; Sahni VA; Sadow CA; Forgione K; Mauri G; Morrison PR; Catalano PJ; Silverman SG
    Clin Radiol; 2014 Apr; 69(4):410-5. PubMed ID: 24411824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
    Thulkar S; Chawla M; Sharma P; Malhotra A; Kumar R
    Clin Nucl Med; 2012 May; 37(5):498-501. PubMed ID: 22475904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
    Lin E; Agoff N
    Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.